Community based study of respiratory morbidity in prematurely born infants Source: Eur Respir J 2003; 22: Suppl. 45, 139s Year: 2003
Viral lower respiratory tract infections and respiratory morbidity in prematurely born infants at follow up Source: Annual Congress 2006 - Bronchiolitis in infancy, treatment and outcome Year: 2006
Risk factors for respiratory syncytial virus (RSV) related hospitalization in preterm infants: A Dutch birth cohort study Source: Annual Congress 2010 - From viral bronchiolitis to recurrent pneumonia in childhood: diagnosis, treatment and underlying factors Year: 2010
Viral lower respiratory tract infections in prematurely born infants and the cost of care in infancy Source: Annual Congress 2010 - Paediatric and neonatal intensive care Year: 2010
RSV lower respiratory tract infection and cytokine profile in prematurely born infants Source: Annual Congress 2006 - Bronchiolitis in infancy, treatment and outcome Year: 2006
Rhinovirus infection and healthcare utilisation in prematurely born infants Source: Eur Respir J 2013; 42: 1029-1036 Year: 2013
In-hospital and midterm post-discharge complications of adults hospitalised with respiratory syncytial virus infection in France, 2017–2019: an observational study Source: Eur Respir J, 59 (3) 2100651; 10.1183/13993003.00651-2021 Year: 2022
Respiratory function in eight year old prematurely born BPD children according to hospitalisation for respiratory syncytial virus (RSV) infection in the first two years Source: Eur Respir J 2007; 30: Suppl. 51, 746s Year: 2007
Premorbid lung function, respiratory syncytial virus infection and chronic respiratory morbidity in prematurely born infants Source: Annual Congress 2005 - Pulmonary function outcome, respiratory morbidity in prematurely born children and acute lung injury Year: 2005
Rhinovirus lower respiratory tract infections and healthcare utilisation of prematurely born infants during infancy Source: Annual Congress 2011 - Viral respiratory infections in children: causes and consequences Year: 2011
Efficacy and safety of palivizumab in preterm infants 29-32 weeks gestational age without chronic lung disease to prevent serious respiratory syncytial virus respiratory tract infection Source: Eur Respir J 2002; 20: Suppl. 38, 531s Year: 2002
Small airway function in prematurely born infants following viral infection Source: Annual Congress 2011 - Innate and exogenous factors in childhood respiratory infection Year: 2011
Epidemiology of severe respiratory syncytial virus infection in Ethiopian infants : A prospective study Source: Virtual Congress 2020 – Worldwide respiratory disease across the full spectrum Year: 2020
Impact of respiratory syncytial virus infection and palivizumab on severe acute lower respiratory infection during the first 6 months of life in a cohort of Colombian infants. Source: International Congress 2018 – Clinical problems in paediatric pulmonology Year: 2018
Infant lung function and subsequent respiratory morbidity during the first year of life in preterm infants Source: Annual Congress 2011 - New insights in paediatric respiratory physiology Year: 2011
Prospective study on the contribution of respiratory syncytial virus (RSV) to acute lower respiratory tract infections (ALRTI) in young hospitalised children Source: Eur Respir J 2004; 24: Suppl. 48, 622s Year: 2004
Prevalence of respiratory syncytial virus (RSV) hospitalisation, and subsequent airway symptoms in late preterm infants Source: Annual Congress 2008 - Paediatric respiratory epidemiology II: air pollution studies and infectious disease epidemiology Year: 2008
Lung function of prematurely born infants pre and post viral lower respiratory tract infections Source: Annual Congress 2010 - Ventilating the premature lung: current practice and outcomes Year: 2010
Longitudinal evaluation of respiratory morbidity 21 years after low birthweight and premature birth Source: Eur Respir J 2003; 22: Suppl. 45, 140s Year: 2003